Order Article Reprints

Giraudet AL, Vinceneux A, Pretet V, Paquet E, Lajusticia AS, Khayi F, Badel JN, Boyle H, Flechon A, Kryza D. Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma. Pharmaceuticals. 2023; 16(7):995. https://doi.org/10.3390/ph16070995

Giraudet, Anne Laure, Armelle Vinceneux, Valentin Pretet, Emilie Paquet, Alicia Sanchez Lajusticia, Fouzi Khayi, Jean Noël Badel, Helen Boyle, Aude Flechon, and David Kryza. 2023. "Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma" Pharmaceuticals 16, no. 7: 995. https://doi.org/10.3390/ph16070995

Giraudet, A. L., Vinceneux, A., Pretet, V., Paquet, E., Lajusticia, A. S., Khayi, F., Badel, J. N., Boyle, H., Flechon, A., & Kryza, D. (2023). Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma. Pharmaceuticals, 16(7), 995. https://doi.org/10.3390/ph16070995